
CAS Number93957-54-1
Synonyms(3S,5R,6E)-7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid; fluvastatin; FLUVASTATIN NA; Lipaxan; MFCD00929076; (3R,5S,6E)-7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid; Lescol; (3R,5S,6E)-rel-7-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid; (3S,5R,6E)-7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (±)-(3R*,5S*,6E)-7-[3-(p-fluorophenyl)-1-isopropylindol-2-yl]-3,5-dihydroxy-6-heptenoate; FLUVASTATIN SODIUM; Primexin
Molecular FormulaC24H26FNO4
Molecular Weight411.47
Purity98%
Density1.2±0.1 g/cm3
Boiling Point681.8±55.0 °C at 760 mmHg
Melting Point194-197ºC
Appearancesolid
Symbol
Signal WordWarning
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 93957-54-1 |
| Catalog No. | 2A-9010592 |
| Chinese Name | 氟伐他汀 |
| Synonyms | (3S,5R,6E)-7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid; fluvastatin; FLUVASTATIN NA; Lipaxan; MFCD00929076; (3R,5S,6E)-7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid; Lescol; (3R,5S,6E)-rel-7-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid; (3S,5R,6E)-7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (±)-(3R*,5S*,6E)-7-[3-(p-fluorophenyl)-1-isopropylindol-2-yl]-3,5-dihydroxy-6-heptenoate; FLUVASTATIN SODIUM; Primexin |
| Molecular Formula | C24H26FNO4 |
| Molecular Weight | 411.47 |
| Purity | 98 |
| Density | 1.2±0.1 g/cm3 |
| Boiling Point | 681.8±55.0 °C at 760 mmHg |
| Melting Point | 194-197ºC |
| Appearance | solid |
| Storage Condition | 2-8℃ |
| Packaging | III |
| Application | Fluvastatin (Leschol) can inhibit HMG-CoA reductase activity with an IC50 of 8 nM. |
| MDL Number | C24H26FNO4 |
| SMILES | CC(C)n1c(C=CC(O)CC(O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21 |
| InChI | InChI=1S/C24H26FNO4/c1-15(2)26-21-6-4-3-5-20(21)24(16-7-9-17(25)10-8-16)22(26)12-11-18(27)13-19(28)14-23(29)30/h3-12,15,18-19,27-28H,13-14H2,1-2H3,(H,29,30)/b12-11+/t18-,19+/m1/s1 |
| InChI Key | FJLGEFLZQAZZCD-DBBWNDPISA-N |
| Hazard Symbols | 3 |
| MSDS | msds/10592_1_93957_54_1.pdf |
| Transport Info | Product name: Fluvastatin |
| Related Products in API & Advanced Intermediates | ||
|---|---|---|
| Fentanyl | 437-38-7 | 2A-9010495 |
| Fluconazole | 86386-73-4 | 2A-9010544 |
| Fluoxetine HCl; Fluoxetine hydrochloride | 56296-78-7 | 2A-9010571 |
| Fluphenazine | 69-23-8 | 2A-9010573 |
| Fluphenazine enanthate | 2A-301657 | 2A-9010574 |
| Fluvastatin sodium | 93957-55-2 | 2A-9010593 |
| Fluvoxamine | 54739-18-3 | 2A-9010594 |
| Formoterol | 73573-87-2 | 2A-9010605 |
| Formoterol fumarate dihydrate | 2519-30-4 | 2A-9010606 |
| Fosinopril | 98048-97-6 | 2A-9010617 |
| Browse all API & Advanced Intermediates products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA